BTSG — BrightSpring Health Services Inc. price, chart and key statistics

Price data

Price

$71.21

YTD price return

+90.15%

YTD total return

+90.15%

Market cap

14.2B2024-03 1.3B2026-11 14.2B+1006.1% over the window

Enterprise value

15.8B

Shares outstanding

199M2022-12 117.8M2026-09 199M+68.9% over the window

52W low

$30.64

52W high

$73.75

From 52W high

-3.44%

From 52W low

+132.41%

52W range

94%$30.64–$73.75

Volume

Rel volume

0.55×

30D volume

2.4M

30D $ vol

158.4M

Insider trading

Insider net 1WNo open-market insider purchase or sale with a transaction date in the last 7 days, as filed on Form 4.

none

Insider net 1MNo open-market insider purchase or sale with a transaction date in the last 30 days, as filed on Form 4.

none

Insider net 3M0 insider-days of buying (no priced lot) and 1 of selling ($874K) in the last 91 days, by transaction date, open-market transactions only — awards, exercises, tax withholding and employee-plan purchases are not counted. A Form 4 is filed within two business days of the trade, so the newest days may not be in yet.

−$874K

Insider net 1Y0 insider-days of buying (no priced lot) and 11 of selling ($3.36B) in the last 365 days, by transaction date, open-market transactions only — awards, exercises, tax withholding and employee-plan purchases are not counted. A Form 4 is filed within two business days of the trade, so the newest days may not be in yet.

−$3.36B

Form 4 transactions by trade date, as filed; latest on file 2026-09-14.

Fundamentals

Sales (ttm)

15.3B2022-12 6.6B2026-09 15.3B+129.8% over the window

Sales/share

$76.642022-12 $56.332026-09 $76.64+36.1% over the window

EPS (ttm)

$1.852022-12 -$0.462026-09 $1.85-503.0% over the window

FCF (ttm)

492.4M2022-12 -74.8M2026-09 492.4M-758.6% over the window

FCF/share

$2.472022-12 -$0.632026-09 $2.47-490.0% over the window

Book value/share

$10.942023-12 $4.962026-09 $10.94+120.5% over the window

Net margin

2.69%2022-12 -0.8%2026-09 2.7%-431.2% over the window

ROE

18.85%2023-12 -26.4%2026-09 18.8%-171.3% over the window

ROA

6.55%2023-12 -2.8%2026-09 6.5%-334.3% over the window

Debt / equity

0.99×2023-12 5.702026-09 0.99-82.7% over the window

Current ratio

1.622023-12 1.172026-09 1.62+38.6% over the window

Growth (CAGR, ttm) · 10Y

Sales

+25.99%2025-09-30 → 2026-09-3012.1B → 15.3B (+26.0% total)+28.28%2023-12-31 → 2026-09-307.7B → 15.3B (+98.3% total)n/an/a

Net income

+216.86%2025-09-30 → 2026-09-30129.6M → 410.3M (+216.6% total)n/an/an/a

FCF

+78.42%2025-09-30 → 2026-09-30276.1M → 492.4M (+78.3% total)+59.16%2023-12-31 → 2026-09-30137.3M → 492.4M (+258.8% total)n/an/a

Shares

+10.34%2025-09-30 → 2026-09-30180.4M → 199M (+10.3% total)+19.07%2023-09-30 → 2026-09-30117.9M → 199M (+68.8% total)n/an/a

Per-share growth (CAGR, ttm) · 10Y

EPS

+204.05%2025-09-30 → 2026-09-30$0.61 → $1.85 (+203.8% total)n/an/an/a

Sales/share

+14.18%2025-09-30 → 2026-09-30$67.13 → $76.64 (+14.2% total)+6.03%2023-12-31 → 2026-09-30$65.26 → $76.64 (+17.4% total)n/an/a

FCF/share

+61.70%2025-09-30 → 2026-09-30$1.53 → $2.47 (+61.6% total)+31.55%2023-12-31 → 2026-09-30$1.16 → $2.47 (+112.5% total)n/an/a

Book value/share

+8.48%2025-09-30 → 2026-09-30$10.08 → $10.94 (+8.5% total)+33.32%2023-12-31 → 2026-09-30$4.96 → $10.94 (+120.5% total)n/an/a

Price

+124.41%2025-11-13 → 2026-11-13$31.75 → $71.21 (+124.3% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+94.94%2024-01-26 → 2026-11-13$11.00 → $71.21 (+547.4% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.n/an/a

Total return

+124.41%2025-11-13 → 2026-11-13$31.75 → $71.21 (+124.3% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+94.94%2024-01-26 → 2026-11-13$11.00 → $71.21 (+547.4% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.n/an/a

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.

38.4×2024-03 -8.292026-11 34.54-516.8% over the window

Fwd P/E

29.4×

P/S (ttm)Market cap ÷ TTM revenue.

0.9×2024-03 0.172026-11 0.93+457.8% over the window

P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.

6.5×2024-03 2.192026-11 6.51+197.1% over the window

P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).

28.8×2024-03 9.332026-11 28.78+208.3% over the window

EV/EBITDA (fy)

23.3×

EV/Sales (ttm)

1.0×

FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.

3.48%2023-12 10.7%2026-09 4.4%-59.3% over the window

Buyback yield (realized, 1y)1 − shares_at(2026-09-30) ÷ shares_at(2025-09-30) = 1 − 199.0M ÷ 180.4M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.

-10.34%

Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (-10.34%) + dividends paid over that year ($0) ÷ market_cap_at(2025-09-30) ($5.3B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.

-10.34%

Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($163.2M) ÷ today's market cap ($14.2B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.

1.15%2023-12 0.1%2026-09 1.4%+2750.4% over the window

Shareholder yield (cash, ttm)(TTM buybacks net of issuance $163.2M + TTM dividends $0) ÷ today's market cap ($14.2B). Same caveat as the cash buyback yield.

1.15%2023-12 0.1%2026-09 1.4%+2750.4% over the window